本文へ移動
cccskills
無料GitHub で公開

enda-glucocorticoid-injection-kit-training

Recommends equipping every patient with primary adrenal insufficiency (PAI) with a glucocorticoid injection kit for emergency self‑administration and providing training on its use. Trigger when preparing a PAI patient for stress dosing, adrenal crisis prevention, or when prescribing glucocorticoid replacement and needing to ensure emergency preparedness.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.8 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Provide Glucocorticoid Injection Kit for Emergency Use and Training on Administration

STEP 1 — Gather Information

Confirm diagnosis of PAI via low cortisol with elevated ACTH or failed ACTH stimulation test; review current glucocorticoid and mineralocorticoid doses; assess patient age, cognitive status, and ability to perform self‑injection; verify presence of steroid emergency card and medical alert jewelry.

STEP 2 — Rule In / Rule Out

Rule in if PAI is confirmed and the patient is at risk for adrenal crisis (e.g., prior crisis, intercurrent illness, pregnancy, or planned stressors); rule out if PAI is excluded or the patient lacks capacity for self‑injection and no trained caregiver is available.

STEP 3 — Classify or Stratify

Stratify by age and caregiver availability: adults and adolescents who can self‑inject receive a kit for self‑use; young children or those with cognitive impairment receive a kit designated for caregiver administration.

STEP 4 — Decide

Prescribe a hydrocortisone sodium succinate 100 mg vial with syringe and alcohol swabs, provide a written sick‑day rule sheet, demonstrate IM or SC injection technique, issue or update steroid emergency card and medical alert bracelet, and schedule reinforcement training at each follow‑up visit.

Clinical Guardrails / Mimics / Pitfalls

Do not delay kit issuance pending specialist referral; do not rely on oral dosing alone during suspected adrenal crisis; avoid dexamethasone as first‑line emergency glucocorticoid because it lacks mineralocorticoid activity; ensure patient knows to inject immediately for fever > 38°C, persistent vomiting, trauma, or inability to retain oral meds; do not substitute kit with suppositories unless vomiting precludes injection and suppositories are available.

Concrete Clinical Example

A 34‑year‑old woman with newly diagnosed autoimmune PAI is started on hydrocortisone 20 mg morning, 10 mg evening and fludrocortisone 0.1 mg daily. At the initiation visit, PAI is confirmed, she is taught to self‑inject 100 mg hydrocortisone IM, receives an emergency kit, steroid card, and instruction to double her oral dose for fever > 38°C and to inject if she cannot keep pills down.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する